Abstract
Fungi are eukaryotic, unicellular, or filamentous organisms that lack chlorophyll, have chitinous cell walls, and reproduce asexually, sexually, or both ways. All available evidence indicates that humans and animals contract most fungal infections by exposure to infectious particles originating from saprophytic moulds and yeasts growing in nature. Of more than 100,000 fungal species in our environment, only about 150 are known to be pathogenic. Their ability to invade body tissues and to produce disease depends on the virulence of the infectious particle, the infecting dose, the route of infection, the resistance or immune status of the host, the organs affected, and the coexistence of infections and other underlying medical conditions. A few fungi, such as the Candida spp., are endogenous, occurring as commensals on the skin and mucous membranes and in the gastrointestinal tract.1,2 These fungi, which are part of the normal body flora, are opportunists that only rarely infect the noncompromised, healthy individual. The Prototheca spp. are not fungi, but are considered by most taxonomists to be achloric mutants of green algae of the genus Chlorella.3 Nevertheless, diseases caused by the protothecae have traditionally fallen within the province of medical mycology and are therefore included in this chapter. For detailed information on the taxonomy of the fungi, several texts are recommended.2–5
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Introduction
Mackowiak PA. The normal microbial flora. N Engl J Med 1982; 307: 83–93.
Emmons CW, Binford CH, Utz JP, Kwon-Chung KJ. Medical mycology. 3d Ed. Philadelphia: Lea and Febiger, 1977.
Chandler FW, Kaplan W, Ajello L. Color atlas and text of the histopathology of mycotic diseases. Chicago: Year Book Medical, 1980.
McGinnis MR. Laboratory handbook of medical mycology. New York: Academic Press, 1980.
Rippon JW. Medical mycology: The pathogenic fungi and the pathogenic actinomycetes. 3rd Ed. Philadelphia: W.B. Saunders, 1988.
Shaffer PJ, Medoff G, Kobayashi GS. New directions in diagnosis and treatment of fungus infections. Semin Infect Dis 1979; 2: 193–216.
Larson DM, Eckman Mr, Alber RL, Goldschmidt VG. Primary cutaneous (inoculation) blastomycosis: An occupational hazard to pathologists. Am J Clin Pathol 1983; 79: 253–255.
Newhouse M, Sanchis J, Bienenstock J. Lung defense mechanisms (Part 1). N Engl J Med 1976; 295: 990–998.
Williams DM, Krick JA, Remington JA. Pulmonary infection in the compromised host, part I. Am Rev Respir Dis 1976: 114: 359–394.
Ray TL. Fungal infections in the immunocompromised host. Med Clin North Am 1980; 64: 955–966.
Hawkins C, Armstrong D. Fungal infections in the immunocompromised host. Clin Haematol 1984; 13: 599–630.
Krick Ja, Remington JS. Opportunistic invasive fungal infections in patients with leukemia and lymphoma. Clin Haematol 1976; 5: 249–310.
Rosen PP. Opportunistic fungal infections in patients with neoplastic diseases. Pathol Annu 1976; 11: 255–315.
Cho SY, Choi HY. Opportunistic fungal infection among cancer patients: A ten-year autopsy study. Am J Clin Pathol 1979; 72: 617–621.
Nash G. Pathologic features of the lung in the immunocompromised host. Hum Pathol 1982; 13: 841–858.
Nash G, Fligiel S. Pathologic features of the lung in the acquired immune deficiency syndrome (AIDS): An autopsy study of seventeen homosexual males. Am J Clin Pathol 1984; 81: 6–12.
Chandler FW. Pathology of the mycoses in patients with the acquired immunodeficiency syndrome (AIDS). Curr Top Med Mycol 1985; 1: 1–23.
Warnock DW, Richardson MD, eds. Fungal infection in the compromised patient. New York: Wiley, 1982.
Grieco MH. Humoral and cellular responses to infection. In: Grieco MH, ed. Infections in the abnormal host. New York: Yorke Medical, 1980: 131–304.
Chandra RK, ed. Primary and secondary immunodeficiency disorders. New York: Churchill Livingstone, 1983.
Elliott K, Whelan J, eds. Enzyme defects and immune dysfunction. Ciba Foundation Symposium No. 68. Amsterdam: Excerpta Medica, 1979.
Thomson RB, Jr., Roberts DG. A practical approach to the diagnosis of fungal infections of the respiratory tract. Clin Lab Med 1982; 2: 321–342.
Chandler FW, Watts JC. Pathologic diagnosis of fungal infections. Chicago: ASCP Press, 1987.
Palmer DF, Kaufman L, Kaplan W, Cavallaro JJ. Serodiagnosis of mycotic diseases. Springfield: Thomas, 1977.
Kaufman L, Reiss E. Serodiagnosis of fungal diseases. In: Lennett EH, ed. Manual of clinical microbiology. 4th Ed. Washington DC: American Society for Microbiology, 1985: 924–944.
Schwarz J. The diagnosis of deep mycoses by morphologic methods. Hum Pathol 1982; 13: 519–533.
Bancroft JD, Stevens A, eds. Theory and practice of histological techniques. London: Churchill Livingstone, 1977.
Kennedy A. Basic techniques in diagnostic histopathology. London: Churchill Livingstone, 1977.
Sheehan DC, Hnapchak BB. Theory and practice of histotechnology. 3d Ed. St. Louis: CV Mosby, 1980.
Elias JM. Principles and techniques in diagnostic histopathology. Park Ridge: Noyes, 1982.
Prophet EB, Mills B, Arrington JB, Sobin LH, eds. Laboratory Methods in Histotechnology. Washington, D.C.: American Registry of Pathology, 1992.
Vacca LL. Laboratory manual of histochemistry. New York: Raven, 1985.
Liber AF, Choi HS. Splendore-Hoeppli phenomenon about silk sutures in tissue. Arch Pathol Lab Med 1973; 95: 217–220.
Kwon-Chung KJ, Hill WB, Bennett JE. New, special stain for histopathological diagnosis of cryptococcosis. J Clin Microbiol 1981; 13: 383–387.
Ro JY, Lee SS, Ayala AG. Advantage of Fontana-Masson stain in capsule-deficient cryptococcal infection. Arch Pathol Lab Med 1987; 111: 53–57.
Wheeler MH, Bell AA. Melanins and their importance in pathogenic fungi. Curr Topics Med Mycol 1987; 2: 338–387.
Dixon DM, Polak A. The medically important dematiaceous fungi and their identification. Mycoses 1991; 34: 1–18.
Wood C, Russel-Bell B. Characterization of pigmented fungi by melanin staining. Am J Dermatopathol 1983; 5: 77–81.
Wages DS, Wear DJ. Acid-fastness of fungi in blastomycosis and histoplasmosis. Arch Pathol Lab Med 1982; 106: 440–441.
Graham AR. Fungal autofluorescence with ultraviolet illumination. Am J Clin Pathol 1983; 79: 231–234.
Monheit JE, Cowan DF, Moore DG. Rapid detection of fungi in tissues using calcofluor white and fluorescence microscopy. Arch Pathol Lab Med 1984; 108: 616–618.
Kaplan W, Kraft DE. Demonstration of pathogenic fungi in formalin-fixed tissues by immunofluorescence. Am J Clin Pathol 1969; 52: 420–432.
Kaplan W. Practical application of fluorescent antibody procedures in medical mycology. In: Mycoses. Sci Pub No 304. Washington DC: Pan American Health Organization, 1975: 178–185.
Russell B, Beckett JH, Jacobs PH. Immunoperoxidase localization of Sporothrix sche. cckii and Cryptococcus neoformans. Staining of tissue sections fixed in 4% formaldehyde solution and embedded in paraffin. Arch Dermatol 1979; 115: 433–435.
El Nageeb S, Hay RJ. Immunoperoxidase staining in the recognition of Aspergillus infections. Histopathology 1981; 5: 437–444.
Humphrey DM, Weiner MH. Candidal antigen detection in pulmonary candidiasis. Am J Med 1983; 74: 630640.
Klatt EC, Cosgrove M, Meyer RR. Rapid diagnosis of disseminated histoplasmosis in tissues. Arch Pathol Lab Med 1986; 110: 1173–1175.
Moskowitz LB, Ganjei P, Ziegels-Weissman J, et al. Immunohistologic identification of fungi in systemic and cutaneous mycoses. Arch Pathol Lab Med 1986; 110: 433–436.
Baker RD, ed. The pathologic anatomy of mycoses: Human infection with fungi, actinomycetes and algae. Berlin: Springer-Verlag, 1971.
Conant NF, Smith DT, Baker RD, Callaway JL. Manual of clinical mycology. 3d Ed. Philadelphia: WB Saunders, 1971.
Binford CH, Dooley JR. Diseases caused by fungi and actinomycetes. In: Binford CH, Connor DH, eds. Pathology of tropical and extraordinary diseases. Washington DC: Armed Forces Institute of Pathology, 1976: 551–609.
Histoplasmosis Capsulati
Ajello L, Chick EW, Furcolow ML, eds. Histoplasmosis. Proceedings of the second national conference. Springfield: ‘Thomas, 1971.
Domer JE, Moser SA. Histoplasmosis-a review. Rev Med Vet Mycol 1980; 15: 159–182.
Schwarz J. Histoplasmosis. New York: Praeger, 1981.
Schwarz J, Baum GL, Floyd H. The pathogenesis of “epidemic” histoplasmosis. Ann NY Acad Sci 1960; 89: 47–58.
Goodwin RA, Jr., Des Prez RM. Histoplasmosis. State of the art. Am Rev. Respir Dis 1978; 117: 929–956.
Davies SF, Khan M, Sarosi GA. Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a non-endemic area. Am J Med 1978; 64: 94100.
Goodwin RA, Jr., Shapiro JL, Thurman GH, Thurman SS, Des Prez RM. Disseminated histoplasmosis: Clinical and pathologic correlations. Medicine (Baltimore) 1980; 59: 1–33.
Kauffman CA, Israel KS, Smith JW, White AC, Schwarz J, Brooks GF. Histoplasmosis in immunosuppressed patients. Am J Med 1978; 64: 923–932.
Wheat LJ, Slama TG, Norton JA, et al. Risk factors for disseminated or fatal histoplasmosis. Ann Intern Med 1982; 96: 159–163.
Baker RD. Histoplasmosis in routine autopsies. Am J Clin Pathol 1964; 41: 457–470.
Vanek J, Schwarz J. The gamut of histoplasmosis. Am J Med 1971; 50: 89–104.
Straus SE, Jacobson ES. The spectrum of histoplasmosis in a general hospital: A review of 55 cases diagnosed at Barnes Hospital between 1966 and 1977. Am J Med Sci 1980; 279: 147–158.
Sarosi GA, Davies SF. Histoplasma capsulatum pneumonia. In: Pennington JE, ed. Respiratory infections: Diagnosis and management. New York: Raven, 1983:375379.
Sutliff WD. Histoplasmosis in Veterans Administration hospitals in middle America. Mycopathologia 1983; 83: 57–62.
Bennish M; Radkowski MA, Rippon JW. Cavitation in acute histoplasmosis. Chest 1983; 84: 496–497.
Sathapatavavongs B, Batteiger BE, Wheat J, Slama TG, Wass JL. Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks. Medicine (Baltimore) 1983; 62: 263–270.
Walsh TJ, Catchatourian R, Cohen H. Disseminated histoplasmosis complicating bone marrow transplantation. Am J Clin Pathol 1983; 79: 509–511.
Wheat LJ, Smith EJ, Sathapatayavongs B, et al. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch, Intern Med 1983; 143: 703–707.
Bonner JR, Alexander WJ, Dismukes WE, et al. Disseminated histoplasmosis in patients with the acquired immune deficiency syndrome. Arch Intern Med 1984; 144: 2178–2181.
Wheat LJ, Small CB. Disseminated histoplasmosis in the acquired immune deficiency syndrome. Arch Intern Med 1984; 144: 2147–2149.
Wheat IT Slama TG, Zeckel ML. Histoplasmosis in the acquired immune deficiency syndrome. Am J Med 1985; 78: 203–210.
Minamoto G, Armstrong D. Fungal infections in AIDS: Histoplasmosis and coccidioidomycosis. Infect Dis Clin North Am 1988; 2: 447–456.
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 43–1991. A 27-year-old man with AIDS, a cough, fever, and pulmonary infiltrates. N Engl J Med 1991; 325: 1228–1239.
Kaur J, Myers AM. Homosexuality, steroid therapy, and histoplasmosis (letter). Ann Intern Med 1983; 99: 567.
Lehmann PF, Gibbons J, Senitzer D, Ribner BS, Freimer EH. T-lymphocyte abnormalities in disseminated histoplasmosis. Am J Med 1983; 75: 790–794.
Zeanah CH, Zusman J. Mediastinal and cervical histoplasmosis simulating malignancy. Am J Dis Child 1979; 133: 47–49.
Gaebler JW, Kleiman MB, Cohen M, et al. Differentiation of lymphoma from histoplasmosis in children with mediastinal masses. J Pediatr 1984; 104: 706–709.
Kurtin PL, McKinsey DS, Gupta MR, Driks M. Histoplasmosis in patients with the acquired immunodeficiency syndrome: Hematologic and bone marrow manifestations. Am J Clin Pathol 1990; 93: 367–372.
Crispell KR, Parson W, Hamlin J, Hollifield G. Addison’s disease associated with histoplasmosis: Report of four cases and review of the literature. Am J Med 1956; 20: 23–29.
Canlas MS, Dillon ML Jr. Histoplasma capsulatum endocarditis: Report of a case following heart surgery. Angiology 1977; 28: 454–463.
Gaynes RP, Gardner P, Causey W. Prosthetic valve endocarditis caused by Histoplasma capsulatum. Arch Intern Med 1981; 141: 1533–1537.
Strimlan CV, Dines DE, Payne WS. Mediastinal granuloma. Mayo Clin Proc 1975; 50: 702–705.
Goodwin RA, Jr., Owens FT, Snell JD, et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 1976; 55: 413–452.
Wheat LJ, Wass J, Norton J, Kohler RB, French ML. Cavitary histoplasmosis occurring during two large urban outbreaks. Analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore) 1984; 63: 201–209.
Schwarz J, Baum GL. Fungus diseases of the lungs. Pulmonary histoplasmosis. Semin Roentgenol 1970; 5: 13–28.
Connell JW, Muhm JR. Radiographic manifestations of pulmonary histoplasmosis: A 10-year review. Radiology 1976; 121: 281–285.
Goodwin RA, Jr., Snell JD. The enlarging histoplasmoma. Am Rev Respir Dis 1969; 100: 1–12.
Silverman FN. Roentgenographic aspects of histoplasmosis. In: Sweeny HC, ed. Histoplasmosis. Springfield: Thomas, 1960: 337–381.
Whitehouse WM, Davey WM, Engelke OK, Holt JF. Roentgen findings in histoplasmin-positive school children. J Mich Med Soc 1959; 58: 1266–1269.
Binford CH. Histoplasmosis: tissue reactions and morphologic variations of the fungus. Am J Clin Pathol 1955; 25: 25–36.
Reynolds RJ, III, Penn RL, Grafton WD, George RB. Tissue morphology of Histoplasma capsulatum in acute histoplasmosis. Am Rev Respir Dis 1984; 130: 317–320.
Hutton JP, Durham JB, Miller DP, Everett ED. Hyphal forms of Histoplasma capsulatum. A common manifestation of intravascular infections. Arch Pathol Lab Med 1985; 109: 330–332.
Puckett TK. Pulmonary histoplasmosis: A study of twenty-two cases with the identification of Histoplasma capsulatum in resected tissues. Am Rev Tuberc 1963; 67: 453–476.
Ulbright TM, Katzenstein ALA. Solitary necrotizing granulomas of the lung. Am J Surg Pathol 1980; 4: 13–28.
Girard DE, Fred HL, Bradshaw MW, Blakely RW, Ettlinger R. Disseminated histoplasmosis diagnosed from peripheral blood film. South Med J 1977; 70: 6566.
Henochowicz S, Sahovic E, Pistole M, Rodrigues M, Macher A. Histoplasmosis diagnosed on peripheral blood smear from a patient with AIDS. JAMA 1985; 253: 3148.
Wheat LJ, Connolly-Stringfield P, Blair R, et al. Histoplasmosis relapse in patients with AIDS: Detection using Histoplasma capsulatum var. capsulatum antigen levels. Ann Intern Med 1991; 115: 936–941.
Hawkins SS, Gregory DW, Alford RH. Progressive dis seminated histoplasmosis: favorable response to ketoconazole. Ann Intern Med 1981; 95: 446–449.
Slama TG. Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole. Proceedings of a symposium on new developments in therapy for the mycoses. Am J Med 1983; 74: 70–73.
Histoplasmosis Duboisii
Vanbreuseghem R. L’histoplasmose africaine un histoplasmose causes pour Histoplasma duboisii Vanbreuseghem 1952. Bull Acad R Med Belg 1964; 4: 543–585.
Schwarz J. African histoplasmosis (part 2). In: Baker RD, ed. The pathologic anatomy of mycoses: Human infection with fungi, actinomycetes and algae. Berlin: Springer-Verlag, 1971: 139–146.
Yamato H, Hitomi H, Maekawa S, Mimura K. A case of histoplasmosis. Acta Med Okayama 1957; 11: 347–364.
Coulanges P, Raveloarison G, Ravisse P. Existence of histoplasmosis with Histoplasma duboisii outside Continental Africa (on the first Malagash case). Bull Soc Pathol Exot Filiales 1982; 75: 400–403.
Cockshott WP, Lucas AO. Histoplasma duboisii. Q J Med 1964; 33: 223–238.
Walker J, Spooner ETC. Natural infection of the African baboon (Papio papio) with the large cell form of histoplasmosis. J Pathol Bacteriol 1960; 8: 436–439.
Williams AO, Lawson EA, Lucas AO. African histoplasmosis due to Histoplasma duboisii. Arch Pathol 1971; 92: 306–318.
Nethercott JR, Schachter RK, Givan KF, Ryder DE. Histoplasmosis due to Histoplasma capsulatum var. duboisii in a Canadian immigrant. Arch Dermatol 1978; 114: 595–598.
Shore RN, Waltersdorff RL, Edelstein MV, Teske JH. African histoplasmosis in the United States. JAMA 1981; 245: 734.
Lobdell DH, Cappiello MA, Riccio FJ. African histoplasmosis in Connecticut. Conn Med 1982; 46: 187.
Clark BM, Greenwood BB. Pulmonary lesions in African histoplasmosis. J Trop Med Hyg 1968; 71: 4–10.
Lanceley IT Lunn HF, Wilson AMM. Histoplasmosis in an African child. J Pediatr 1961; 59: 756–764.
Quere MA, Basset A, Basset M, Cave L. Histoplasmose generalisee avec localisation orbitopalpebrale et lacunes craniennes. Ann Oculist 1065; 198: 105–114.
Cockshott WP, Lucas AO. Radiological findings in Histoplasma duboisii infections. Br J Radiol 1964; 37: 653660.
Lunn HF. A case of histoplasmosis of bone in East Africa. J Trop Med Hyg 1960; 63: 175–180.
Adekunle OO, Sudhakaran P, Timeyin ED. African histoplasmosis of the jejunum. Report of a case. J Trop Med Hyg 1978; 81: 88–90.
Young CN. North American blastomycosis in South Africa. S Afr Med J 1977; 51: 865.
Brown KGE, Molesworth BD, Boerrigter EGG, et al. Disseminated histoplasmosis duboisii in Malawi. Partial response to sulphonamide/trimethoprim combination. East Afr Med J 1974; 51: 584–590.
Blastomycosis
McDonough ES. Blastomycosis: Epidemiology and biology of its etiologic agent, Ajellomyces dermatitidis. Mycopathologia 1970; 41: 195–201.
Sekhon AS, Jackson FL, Jacobs HJ. Blastomycosis: Report of the first case from Alberta, Canada. Mycopathologia 1982; 79: 65–69.
Tenenbaum MJ, Greenspan J, Kerkering TM. Blastomycosis. CRC Crit Rev Microbiol 1982; 9: 139–163.
Kane J, Righter J, Krajden S, Lester RS. Blastomycosis: A new endemic focus in Canada. Can Med Assoc J 1983; 129: 728–731.
Schwarz J. Epidemiology and epidemics of blastomycosis. Mykosen 1983; 16: 7–14.
Emerson PA, Higgins E, Branfoot A. North American blastomycosis in Africans. Br J Dis Chest 1984; 78: 286291.
Randhawa HS, Khan Z, Gaur S. Blastomyces dermatitidis in India: First report of its isolation from clinical material. Sabouraudia 1983; 21: 215–221.
Sarosi GA, Davies, SF. Blastomycosis. Am Rev Respir Dis 1979; 120: 911–938.
Denton JF, McDonough ES, Ajello L, Ausherman RJ. Isolation of Blastomyces dermatitidis from soil. Science 1961; 133: 1126–1127.
Baum GL, Lerner PI. Primary pulmonary blastomycosis: A laboratory acquired infection. Ann Intern Med 1970; 73: 263–265.
Busey JP, ed. Blastomycosis: I. A review of 198 collected cases in the Veterans Administration hospitals. Am Rev Respir Dis 1964; 89: 659–672.
Witorsch P, Utz JP. North American blastomycosis: A study of 40 patients. Medicine (Baltimore) 1968; 47: 169200.
Vanek J, Schwarz J, Haken S. North Ameirican blastomycosis. Am J Clin Pathol 1970; 54: 384 400.
Schwarz J, Baum GL. Fungus diseases of the lungs. North American blastomycosis. Semin Roentgenol 1970; 5: 40–48.
Cush R, Light RW, George RB. Clinical and roentgenographic manifestations of acute and chronic blastomycosis. Chest 1976; 69: 345–349.
Halvorsen RA, Duncan JD, Merten DJ, Gallis HA, Putman CE. Pulmonary blastomycosis: radiologic manifestations. Radiology 1984; 150: 1–5.
Laskey W, Sarosi GA. The radiologic appearance of pulmonary blastomycosis. Radiology 1978; 126: 35 1357.
Abernathy RS. Clinical manifestations of pulmonary blastomycosis. Ann Intern Med 1959; 51: 707–727.
Inoshita T, Youngberg GA, Boelen LJ, Langston J. Blastomycosis presenting with prostatic involvement: Report of 2 cases and review of the literature. J Urol 1983; 130: 160–162.
Stelling CB, Woodring JH, Rehm SR, Hopper DW, Noble RC. Miliary pulmonary blastomycosis. Radiology 1984; 150: 7–13.
Poe RH, Vassalo CL, Plessingar VA, Pulmonary blastomycosis versus carcinoma: A challenging differential. Am J Med Sci 1972; 263: 145–155.
Kinasewitz GT, Penn RL, George RB. The spectrum and significance of pleural disease in blastomycosis. Chest 1984; 86: 580–584.
Onal E, Lopata M, Lourence RV. Disseminated pulmonary blastomycosis in an immunosuppressed patient: Diagnosis by fiberoptic bronchoscopy. Am Rev Respir Dis 1976; 113: 83–86.
Atkinson JB, McCurley TL. Pulmonary blastomycosis: filamentous forms in an immunocompromised patient with fulminating respiratory failure. Hum Pathol 1983; 14: 186–188.
Laskey WL, Sarosi GA. Endogenous reactivation in blastomycosis. Ann Intern Med 1978; 88: 50–52.
Harding CV. Blastomycosis and opportunistic infections in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991; 115: 1133–1136.
Butka BJ, Bennett SR, Johnson AC. Disseminated inoculation blastomycosis in a renal transplant recipient. Am Rev Respir Dis 1984; 130: 1180–1183.
Schwarz J, Salfelder K. Blastomycosis: a review of 152 cases. In: Grundmann E, Kirsten WH, eds. Current topics in pathology. Berlin: Springer-Verlag, 1977; 65: 165–200.
Chandler FW, Watts JC. Pathologic features of blastomycosis. In: Al-Doory Y, DiSalvo AF, eds. Blastomycosis. New York: Plenum Press, 1992: 189–220.
Tuttle JG, Lichtwardt HE, Altshuler CH. Systemic North American blastomycosis. Report of a case with small forms of blastomycetes. Am J Clin Pathol 1953; 23: 890–897.
Watts JC, Chandler FW, Mihalov ML, Kammeyer PL, Armin AR. Giant forms of Blastomyces dermatitidis in the pulmonary lesions of blastomycosis. Potential confusion with Coccidioides immitis. Am J Clin Pathol 1990; 93: 119122.
Lockwood WR, Allison F, Blair BE, Busey JF. The treatment of North American blastomycosis. Ten years’ experience. Am Rev Respir Dis 1969; 100: 314–320.
Parker JD, Doto IL, Tosh FE. A decade of experience with blastomycosis and its treatment with amphotericin B. Am Rev Respir Dis 1969; 99: 895–902.
Busey JF. Blastomycosis. III. A comparative study of 2-hydroxystilbamidine and amphotericin B therapy. Am Rev Respir Dis 1972; 105: 812–818.
Bradsher RW. Prognosis and therapy of blastomycosis. In: Al-Doory Y, DiSalvo AF, eds. Blastomycosis. New York: Plenum Press, 1992: 237–247.
Short KL, Harty JI, Amin M, Short LF. The use of ketoconazole to treat systemic blastomycosis presenting as acute epididymitis. J Urol 1983; 129: 382–384.
Sanders JS, Sarosi GA, Nollet DJ, Thompson JI. Exfoliative cytology in the rapid diagnosis of pulmonary blastomycosis. Chest 1977; 72: 193–196.
Trumbull ML, Chesney TM. The cytological diagnosis of pulmonary blastomycosis. JAMA 1981; 245: 836–838.
Kaufman L. Immunodiagnosis of blastomycosis. In: Al-Doory Y, DiSalvo AF, eds. Blastomycosis. New York: Plenum Press, 1992: 123–132.
Cryptococcosis
Kaufman L, Blumer S. Cryptococcosis: The awakening giant. In: The black and white yeasts. Sci Pub 356. Washington DC: Pan American Health Organization, 1978: 176–182.
Powell KE, Dahl BA, Weeks RJ, Tosh FE. Airborne Cryptococcus neoformans: Particles from pigeon excreta compatible with alveolar deposition. J Infect Dis 1972; 125: 412–415.
Diamond RD. Cryptococcus neoformans pneumonia. In: Pennington JE, ed. Respiratory infections: Diagnosis and management. New York: Raven, 1983: 341–351.
Nielson JB, Fromtling RA, Bulmer GS. Cryptococcus neoformans: Size range of infectious particles from aerosolized soil. Infect Immun 1977; 17: 634–638.
Littman ML, Walter JE. Cryptococcosis: current status. Am J Med 1968; 45: 922–932.
Lewis RL, Rabinovich S. The wide spectrum of cryptococcal infections. Am J Med 1972; 53: 315–322.
Noble RC, Fajardo LF. Primary cutaneous cryptococcosis: Review and morphologic study. Am J Clin Pathol 1972; 57: 13–22.
Kaplan MH, Rosen PP, Armstrong D. Cryptococcosis in a cancer hospital. Clinical and pathological correlates in forty-six patients. Cancer 1977; 39: 2265–2274.
Kerkering TM, Duma RJ, Shadomy S. The evolution of pulmonary cryptococcosis: Clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 1981; 94: 611–616.
Schimpff SC, Bennett JE. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infections. J Allergy Clin Immunol 1975; 55: 430–441.
Clark RA, Greer D, Atkinson W, Valainis GT, Hyslop N. Spectrum of Cryptococcus neoformans infection in 68 patients infected with human immunodeficiency virus. Rev Infect Dis 1990; 12: 768–777.
Chechani V, Kamholz SL. Pulmonary manifestations of disseminated cryptococcosis in patients with AIDS. Chest 1990; 98: 1060–1066.
Krumholz RA. Pulmonary cryptococcosis: a case due to Cryptococcus albidus. Am Rev Respir Dis 1972; 105: 42 1424.
Lynch JP, III, Schaberg DR, Kissner DG, Kauffman CA. Cryptococcus laurentii lung abscess. Am Rev Respir Dis 1981; 123: 135–138.
Denning DW, Stevens DA, Hamilton JR. Comparison of Guizotia abyssinica seed extract (birdseed) agar with conventional media for selective identification of Cryptococcus neoformans in patients with acquired immunodeficiency syndrome. J Clin Microbiol 1990; 28: 2565–2567.
Sarosi GA, Silberfarb PM, Tosh FE. Cutaneous cryptococcosis: A sentinel of disseminated disease. Arch Dermatol 1971;104:1–3.
Schupbach CW, Wheeler CE, Briggaman RA, Warner NA, Kanof EP. Cutaneous manifestations of disseminated cryptococcosis. Arch Dermatol 1976; 112: 1734 1740.
Massa MG, Doyle JA. Cutaneous cryptococcosis simulating pyoderma gangrenosum. J Am Acad Dermatol 1981; 5: 32–36.
Borton LK, Wintroub BU. Disseminated cryptococcosis presenting as herpetiform lesions in a homosexual man with acquired immunodeficiency syndrome. J Am Acad Dermatol 1984; 10: 387–390.
Rico MJ, Penneys NS. Cutaneous cryptococcosis resembling molluscum contagiosum in a patient with AIDS. Arch Dermatol 1985; 121: 901–902.
Eng RH, Bishburg E, Smith SM, Kapila R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am J Med 1986; 81: 19–23.
Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 234–240.
Campbell GD. Primary pulmonary cryptococcosis. Am Rev Respir Dis1966; 94: 236–243.
Warr W, Bates JH, Stone A. The spectrum of pulmonary cryptococcosis. Ann Intern Med 1968; 69: 1109–1116.
Hammerman KJ, Powell KE, Christianson CS, et al. Pulmonary cryptcoccosis: Clinical forms and treatment. A Center for Disease Control cooperative mycoses study. Am Rev Respir Dis 1973; 108: 1116–1123.
Tynes B, Mason KN, Jennings AE, Bennett JE. Variant forms of pulmonary cryptococcosis. Ann Intern Med 1968; 69: 1117–1125.
Cohen AA, Davis W, Finegold SM. Chronic pulmonary cryptococcosis. Am Rev Respir Dis 1965; 91: 414–423.
Feigin DS. Pulmonary cryptococcosis: Radiologicpathologic correlates of its three forms. AJR 1983; 141: 1262–1272.
Salyer WR. Primary complex of Cryptococcus and pulmonary lymph nodes. J Infect Dis 1974; 130: 74–77.
Baker RD. The primary pulmonary lymph node complex of cryptococcosis. Am J Clin Pathol 1976; 65: 83–92.
Schwarz J, Baum GL. Fungus diseases of the lungs. Cryptococcosis. Semin Roentgenol 1970; 5: 49–54.
Khoury MB, Godwin JD, Ravin CE, Gallis HA, Halvorsen RA, Putman CE. Thoracic cryptococcosis: Immunologic competence and radiologic appearance. AJR 1984; 142: 893–896.
Gordonson J, Birnbaum W, Jacobson G, Sargent EN. Pulmonary cryptococcosis. Radiology 1974; 112: 557561.
Young EJ, Hirsh DD, Fainstein V, Williams TW. Pleural effusions due to Cryptococcus neoformans: A review of the literature and report of two cases with cryptococcal antigen determinations. Am Rev Respir Dis 1980; 121: 743–747.
Fisher BD, Armstrong D. Cryptococcal interstitial pneumonia: Value of antigen determination. N Engl J Med 1977; 297: 1440–1441.
Stansell JD. Fungal disease in HIV-infected persons: Cryptococcosis, histoplasmosis, and coccidioidomycosis. J Thorac Imaging 1991; 66: 153–156.
Kent TH, Layton JM. Massive pulmonary cryptococcosis. Am J Clin Pathol 1962; 38: 596–604.
Bloomfield N, Gordon MA, Elmendorf DF, Jr. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc Soc Exp Biol Med 1963; 114: 64–67.
Diamond RD. Cryptococcus neoformans. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. 2d Ed. New York: Wiley, 1985: 1460–1468.
Perkins W. Pulmonary cryptococcosis: Report on the treatment of nine cases. Chest 1969; 56: 389–394.
Larsen RA, Leal MAE, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med 1990; 113: 183–187.
Sugar AM, Saunders C. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 481–489.
Smith FS, Gibson P, Nicholls TT, Simpson JA. Pulmonary resection for localized lesions of cryptococcosis (torulosis): A review of eight cases. Thorax 1976; 31: 121–126.
Baker RD, Haugh RK. Tissue changes and tissue diagnosis in cryptococcosis. A study of twenty-six cases. Am J Clin Pathol 1955; 25: 14–24.
McDonnell JM, Hutchins GM. Pulmonary cryptococcosis. Hum Pathol 1985; 16: 121–128.
Farmer SG, Komorowski RA. Histologic response to capsule-deficient Cryptococcus neoformans. Arch Pathol 1973; 96: 383–387.
Rosenheim SH, Schwarz J. Cavitary pulmonary cryptococcosis complicated by aspergilloma. Am Rev Respir Dis 1975; 111: 549–553.
Gutierrez F, Fu YS, Lurie HI. Cryptococcosis histologically resembling histoplasmosis. A light and electron microscopical study. Arch Pathol 1975; 99: 347–352.
Harding SA, Scheld WM, Feldman PS, Sande MA. Pulmonary infection with capsule-deficient Cryptococcus neoformans. Virchows Arch [A] 1979; 382: 113–118.
Paracoccidioidomycosis
Angulo-Ortega A, Pollak L. Paracoccidioidomycosis. In: Baker RD, ed. The pathologic anatomy of mycoses: Human infection with fungi, actinomycetes and algae. Berlin: Springer-Verlag, 1971: 507–576.
Giraldo R, Restrepo A, Gutierrez F, et al. Pathogenesis of paracoccidioidomycosis: A model based on the study of 46 patients. Mycopathologia 1976; 58: 63–70.
Restrepo A, Robledo M, Giraldo R, et al. The gamut of paracoccidioidomycosis. Am J Med 1976; 61: 33–42.
Fountain FF, Sutliff WD. Paracoccidioidomycosis in the United States. Am Rev Respir Dis 1969; 99: 89–93.
Kroll JJ, Walzer RA. Paracoccidioidomycosis in the United States. Arch Dermatol 1972; 106: 543–546.
Murray HW, Littman ML, Roberts RB. Disseminated paracoccidioidomycosis (South American blastomycosis) in the United States. Am J Med 1974; 56: 209–220.
Bouza E, Winston DJ, Rhodes J, Hewitt WL. Paracoccidioidomycosis (South American blastomycosis) in the United States. Chest 1977; 72: 100–102.
Restrepo A, Robledo M, Gutierrez F, Sanclemente M, Castaneda E, Calle G. Paracoccidioidomycosis (South American blastomycosis): A study of 39 cases observed in Medellin, Colombia. Am J Trop Med Hyg 1970; 19: 68–76.
Salfelder K, Doehnert G, Doehnert HR. Paracoccidioidomycosis: Anatomic study with complete autopsies. Virchows Arch [A] 1969; 348: 51–76.
Restrepo A. The ecology of Paracoccidioides brasiliensis: A puzzle still unsolved. Sabouraudia 1985; 23: 323–334.
Sugar AM, Restrepo A, Stevens DA. Paracoccidioidomycosis in the immunosuppressed host: Report of a case and review of the literature. Am Rev Respir Dis 1984; 129: 340–342.
Londero AT, Ramos CD, Lopes JOS. Progressive pulmonary paracoccidioidomycosis: A study of 34 cases observed in Rio Grande do Sul (Brazil). Mycopathologia 1978; 63: 53–56.
Londero AT, Severo LC. The gamut of progressive pulmonary paracoccidioidomycosis. Mycopathologia 1981; 75: 65–74.
Schwarz J, Baum GL. Paracoccidioidomycosis (South American blastomycosis). Semin Roentgenol 1970; 5:69–72.
Tuder RM, El Ibrahim R, Godoy CE, DeBrito T. Pathology of the human pulmonary paracoccidioidomycosis. Mycopathologia 1985; 92: 179–188.
Severo LC, Geyer GR, Londero AT, Porto NS, Rizzon CFC. The primary pulmonary lymph node complex in paracoccidioidomycosis. Mycopathologia 1979; 67: 115118.
Londero AT, Severo LC, Ramos CD. Small forms and hyphae of Paracoccidioides brasiliensis in human tissue. Mycopathologia 1980; 72: 17–19.
Tani EM, Franco M. Pulmonary cytology in paracoccidioidomycosis. Acta Cytol 1984; 28: 571–575.
Cohen J. Antifungal chemotherapy. Lancet 1982;ii: 532–537.
Hermans PE, Key TF. Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc 1983; 58: 223231.
Restrepo A, Gomez I, Robledo J, Patino MM, Cano LE. Itraconazole in the treatment of paracoccidioidomycosis. A preliminary report. Rev Infect Dis 1987; 9 (Suppl. 1): S51 - S56.
Sporotrichosis
Lurie HI. Sporotrichosis. In: Baker RD, ed. The pathologic anatomy of mycoses: Human infection with fungi, actinomycetes and algae. Berlin: Springer-Verlag, 1971:
Bullpitt P, Weedon D. Sporotrichosis: A review of 39 cases. Pathology 1978; 10: 249–256.
Lurie HI. Histopathology of sporotrichosis. Arch Pathol 1963; 75: 92–109.
Scott SM, Peasley ED, Crymes TP. Pulmonary sporotrichosis. Report of two cases with cavitation. N Engl J Med 1961; 265: 453–457.
Baum GL, Donnerberg RL, Steward D, Mulligan WJ, Putnam LR. Pulmonary sporotrichosis. N Engl J Med 1969; 280: 410–413.
Berson SD, Brandt FA. Primary pulmonary sporotrichosis with unusual fungal morphology. Thorax 1977; 32: 505–508.
England DM, Hochholzer L. Primary pulmonary sporotrichosis. Report of eight cases with clinicopathologic review. Am J Surg Pathol 1985; 9: 193–204.
England DM, Hochholzer L. Sporothrix infection of the lung without cutaneous disease: Primary pulmonary sporotrichosis. Arch Pathol Lab Med 1987; 111: 298300.
Watts JC, Chandler FW. Primary pulmonary sporotrichosis. Arch Pathol Lab Med 1987; 111: 215–217.
Wilson DE, Mann JJ, Bennett JE, Utz JP. Clinical features of extracutaneous sporotrichosis. Medicine (Baltimore) 1967; 46: 265–279.
Lynch PJ, Voorhees JJ, Harrell ER. Systemic sporotrichosis. Ann Intern Med 1970; 73: 23–30.
Font RI, Jakobiec FA. Granulomatous necrotizing retinochoroiditis caused by Sporotrichum schenckii. Report of a case including immunofluorescence and electron microscopical studies. Arch Ophthalmol 1976; 94: 1513 1519.
Brook CJ, Ravikrishnan KP, Weg JG. Pulmonary and articular sporotrichosis. Am Rev Respir Dis 1977; 116: 141–143.
Friedman SJ, Doyle JA. Extracutaneous sporotrichosis. Int J Dermatol 1983; 22: 171–176.
Smith PW, Loomis GW, Luckasen JL, Osterholm RK. Disseminated cutaneous sporotrichosis. Three illustrative cases. Arch Dermatol 1981; 117: 143–144.
Smith AG, Morgan WKC, Hornick RB, Funk AM, Chronic pulmonary sporotrichosis: report of a case, including morphologic and mycologic studies. Am J Clin Pathol 1970; 54: 401–409.
Schwarz J, Baum GL. Fungus diseases of the lungs. Sporotrichosis. Semin Roentgenol 1970; 5: 55–57.
Comstock C, Wolson AH. Roentgenology of sporotrichosis. Am J Roentgenol Radium Ther Nucl Med 1975; 125: 651–655.
Lurie HI, Still WJS. The “capsule” of Sporotrichum schenckii and the evolution of the asteroid body. A light and electron microscopic study. Sabouraudia 1969; 7: 64–70.
Maberry JD, Mullins JF, Stone OJ. Sporotrichosis with demonstration of hyphae in human tissue. Arch Dermatol 1966; 93: 65–67.
Mohr JA, Patterson CD,Eaton BG, Rhoades ER, Nichols NB. Primary pulmonary sporotrichosis. Am Rev Respir Dis 1972; 106: 260–264.
Kaplan W, Gonzalez-Ochoa A. Application of the fluorescent antibody technique to the rapid diagnosis of sporotrichosis. J Lab Clin Med 1963; 62: 835–841.
Parker JD, Sarosi GA, Tosh FE. Treatment of extracutaneous sporotrichosis. Arch Intern Med 1970; 125: 858–863.
Restrepo A, Robledo J, Gomez I, Tabares AM, Gutierrez R. Itraconazole therapy in lymphangitic and cutaneous sporotrichosis. Arch Dermatol 1986; 122: 413–417.
Rohwedder JJ, Archer G. Pulmonary sporotrichosis: Treatment with miconazole. Am Rev Respir Dis 1976; 114: 403–406.
Baker JH, Goodpasture HC, Kuhns HR, Rinaldi MG. Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole. Arch Pathol Lab Med 1989; 113: 1279–1281.
Gullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP. Sporotrichosis: Recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis 1987; 9: 369–375.
Jung JY, Almond CH, Campbell DC, Elkadi A, Tenorio A. Role of surgery in the management of pulmonary sporotrichosis. J Thorac Cardioavasc Surg 1979; 77: 234–239.
Torulopsosis
Grimley PM, Wright LD, Jennings AE. Torulopsis glabrata infection in man. Am J Clin Pathol 1965; 43: 216223.
Marks MI, Langston C, Eickhoff TC. Torulopsis glabrata-an opportunistic pathogen of man. N Engl J Med 1970; 283: 1131–1135.
Yarrow D, Meyer SA. Proposal for amendment of the diagnosis of the genus Candida Berkhout nom. cons. Int J Syst Bacteriol 1978; 28: 611–615.
McGinnis MR, Ajello L, Beneke ES, et al. Taxonomic and nomenclatural evaluation of the genera Candida and Torulopsis. J Clin Microbiol 1984; 20: 813–814.
Lodder J. The yeasts. A taxonomic study. 2d Ed. Amsterdam: North-Holland, 1970.
Katz D, Pickard RE. Systemic Torulopsis glabrata infection causing shock, fever and coma. Am J Med 1967; 42: 15 1152.
Louria DB, Belvins A, Armstrong D, Burdick R. Lieberman P. Fungemia caused by “nonpathogenic” yeasts. Arch Intern Med 1967; 119: 247–252.
Rodrigues RJ, Shinya H, Wolff WI, Puttlitz D. Torulopsis glabrata fungemia during prolonged intravenous alimentation therapy. N Engl J Med 1971; 284: 540–541.
Pankey GA, Daloviso JR. Fungemia caused by Torulopsis glabrata. Medicine (Baltimore) 1973; 52: 395–403.
Young RC, Bennett JE, Geelhoed GW, Levine AS. Fungemia with compromised host resistance. A study of 70 cases. Ann Intern Med 1974; 80: 605–612.
Valdivieso M, Luna M, Bodey GP, Rodriguez V, Groschel D. Fungemia due to Torulopsis glabrata in the compromised host. Cancer 1976; 38: 1750–1756.
Berkowitz ID, Robboy SJ, Karchmer AW, Kunz LJ. Torulopsis glabrata fungemia-a clinical pathological study. Medicine (Baltimore) 1979; 58: 430–440.
Kauffman CA, Tan JS. Torulopsis glabrata renal infection. Am J Med 1974; 57: 217–224.
Takeuchi H, Tomoyoshi T. Torulopsis infection extensively involving urinary tract. Urology 1983; 22: 173175.
Vordermark JS, II, Modarelli RO, Buck AS. Torulopsis pyelonephritis associated with papillary necrosis. A case report. J Urol 1980; 123: 96–97.
Oldfield FS, Kapica L, Pirozynski WJ. Pulmonary infection due to Torulopsis glabrata. Can Med Assoc J 1968; 98: 165–168.
Aisner J, Sickles EA, Schimpff SC, Young VM, Greene WH, Wiernik PH. Torulopsis glabrata pneumonitis in patients with cancer: Report of three cases. JAMA 1974; 230: 584–585.
Sander LA, Young EJ, Musher DM, Clarridge JE. Torulopsis glabrata pneumonia in a malnourished woman. South Med J 1979; 72: 1477–1479.
Gustke KA, Wu KK. Torulopsis glabrata osteomyelitis: Report of a case. Clin Orthop 1981; 154: 197–200.
Thurston AJ, Gillespie WJ. Torulopsis glabrata osteomyelitis of the spine: A case report and review of the literature. Aust NZ J Surg 1981; 51: 374–376.
Rubin MM, Sanfilippo RJ. Osteomyelitis of the hyoid caused by Torulopsis glabrata in a patient with acquired immunodeficiency syndrome. J Oral Maxillofac Surg 1990; 48: 1217–1219.
Heffner DK, Franklin WA. Endocarditis caused by Torulopsis glabrata. Am J Clin Pathol 1978; 70: 420–423.
Holliday HD, Keipper V, Kaiser AB. Torulopsis glabrata endocarditis. JAMA 1980; 244: 2088–2089.
Miller DD. Postoperative acalculous cholecystitis due to Torulopsis glabrata. Arch Surg 1976; 111: 1404–1405.
Baley JE, Dliegman RM, Annable WL, Dahms BB, Fanaroff AA. Torulopsis glabrata sepsis appearing as necrotizing enterocolitis and endophthalmitis. Am J Dis Child 1984; 138: 965–966.
Wurzel B, Goldberg P, Caroline L, Bozza AT, Kozinn PJ. Torulopsis glabrata meningoencephalitis treated with 5-flucytosine. Ann Intern Med 1972; 77: 814–815.
Fitzsimons RB, Nicholls MD, Billson FA, Robertson TI, Hersey P. Fungal retinitis: A case of Torulopsis glabrata infection treated with miconazole. Br J Ophthalmol 1980; 64: 672–675.
Clark JFJ, Faggett T, Peters B, et al. Ulcerative vaginitis due to Torulopsis glabrata: A case report. J Nati Med Assoc 1978; 70: 913–914.
Tom W, Aaron JS. Esophageal ulcers caused by Torulopsis glabrata in a patient with acquired immune deficiency syndrome. Am J Gastroenterol 1987; 82: 766–768.
Hahn H, Condie F, Bulger RF. Diagnosis of Torulopsis glabrata infection. JAMA 1968; 203: 835–837.
Rose HD, Heckman MG. Persistent fungemia caused by Torulopsis glabrata: Treatment with amphotericin B. Am J Clin Pathol 1970; 54: 205–208.
Corbella X, Carratala J, Castells M, Berlanga B. Fluconazole treatment in Torulopsis glabrata upper urinary tract infection causing ureteral obstruction. J Urol 1992; 147: 1112–1114.
Candidiasis
Rose HD, Varkey B. Deep mycotic infection in the hospitalized adult: A study of 123 patients. Medicine (Baltimore) 1975; 54: 499–507.
DeGregorio MW, Lee WMF, Linker CA, Jacobs RA, Ries CA. Fungal infections in patients with acute leukemia. Am J Med 1982; 73: 543–548.
Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V. Bodey GP. Systemic candidiasis in cancer patients. Am J Med 1984; 77 (4D): 20–27.
Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 1984; 53: 411–419.
Hopfer RL. Mycology of candida infections. In: Bodey GP, Fainstein V, eds. Candidiasis. New York: Raven, 1985: 1–12.
Parker JC, McCloskey JJ, Knauer KA. Pathobiologic features of human candidiasis: a common deep mycosis of the brain, heart and kidney in the altered host. Am J Clin Pathol 1976; 65: 991–1000.
Myerowitz RL, Pazin GJ, Allen CM. Disseminated candidiasis: changes in incidence, underlying diseases, and pathology. Am J Clin Pathol 1977; 68: 29–38.
Kiehn TE, Edwards FF, Armstrong D. The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol 1980; 73: 518–521.
Hughes WT. Systemic candidiasis: A study of 109 fatal cases. Pediatr Infect Dis 1982; 1: 11–18.
Marsh PK, Tally FP, Kellum J, Callow A, Gorbach SL. Candida infections in surgical patients. Ann Surg 1983; 198: 42–47.
Blinkhorn RJ, Adelstein D, Spagnuolo PJ. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol 1989; 27: 236–240.
Kozinn PJ, Taschdjian CL. Candida albicans Saprophyte or pathogen? JAMA 1966; 198: 170–172.
Rippon JW. Medical mycology: The pathogenic fungi and the pathogenic actinomycetes. 3rd Ed. Philadelphia: W.B. Saunders, 1988: 536–581.
Edwards JW, moderator. Severe candidal infections: Clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med 1978; 89: 91–106.
Smith CB. Candidiasis: Pathogenesis, host resistance, and predisposing factors. In: Bodey GP, Fainstein V. eds. Candidiasis. New York: Raven, 1985: 53–70.
Marchevsky A, Rosen MJ, Chrystal G, Kleinerman J. Pulmonary complications of the acquired immunodeficiency syndrome: A clinicopathologic study of 70 cases. Hum Pathol 1985; 16: 659–670.
Myerowitz RL. The pathology of opportunistic infections with pathogenetic, diagnostic, and clinical correlations. New York: Raven, 1983: 95–114.
Kassner EG, Kauffman SL, Yoon JJ, Semiglia M, Kozinn PJ, Goldberg PL. Pulmonary candidiasis in infants: Clinical, radiologic, and pathologic features. AJR 1981; 137: 707–716.
Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors for nosocomial candidemia: A case-control study in adults without leukemia. Am J Med 1989; 87: 614–620.
Masur H, Rosen PP, Armstrong D. Pulmonary disease caused by Candida species. Am J Med 1977; 63: 914–925.
Bodey GP, Fainstein V. Systemic candidiasis. In: Bodey GP, Fainstein V, eds. Candidiasis. New York: Raven, 1985: 135–168.
Ramirez G, Shuster M, Kozub W, Pribor HC. Fatal acute Candida albicans bronchopneumonia: Report of a case. JAMA 1967; 199: 340–342.
Steven PJ, Jameson JW, Philpott CM. Fatal pulmonary candidiasis. Lancet 1972;i:962–963.
Rosenbaum RB, Barber J V, Stevens DA. Candida albicans pneumonia: Diagnosis by pulmonary aspiration, recovery without treatment. Am Rev Respir Dis 1974; 109: 373–378.
Pagani JJ, Libshitz HI. Opportunistic fungal pneumonias in cancer patients. AJR 1981; 137: 1033–1039.
Pagani JJ, Libshitz HI. Radiology of Candida infections. In: Bodey GP, Fainstein V, eds. Candidiasis. New York: Raven, 1985: 71–84.
Dubois PJ, Myerowitz RL, Allen CM. Pathoradiologic correlation of pulmonary candidiasis in immunosuppressed patients. Cancer 1977; 40: 1026–1036.
Bode FR, Paré JAP, Fraser RG. Pulmonary diseases in the compromised host: A review of clinical and roentgenographic manifestations in patients with impaired host defense mechanisms. Medicine (Baltimore) 1974; 53: 255–293.
Buff SJ, McLelland R, Gallis HA, Matthay R, Putman CE. Candida albicans pneumonia: radiographic appearance. AJR 1982; 138: 645–648.
Hietala SO, Jonsson M, Burman LA. Candida albicans pneumonia. Acta Radiol [Diagnl (Stockh) 1982; 23: 507511.
Rose HS, Sheth NK. Pulmonary candidiasis: A clinical and pathologic correlation. Arch Intern Med 1978; 138: 964–965.
Kozinn PJ, Taschdjian CL. Laboratory diagnosis of candidiasis. In: Bodey GP, Fainstein V, eds. Candidiasis. New York: Raven, 1985: 85–110.
Gold, JWM. Opportunistic fungal infections in patients with neoplastic disease. Am J Med 1984; 76: 458–463.
Goldstein E, Hoeprich PD. Problems in the diagnosis and treatment of systemic candidiasis. J Infect Dis 1972; 125: 190–193.
Walsh TJ, Hathorn JW, Sobel JD, et al. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med 1991; 324: 1026–1031.
Utz JP, Drouhet E. Treatment of Candida infections. In: Bodey GP, Fainstein V, eds. Candidiasis. New York: Raven, 1985: 253–269.
Nakamura T. Experimental pulmonary candidiasis in modified rabbits. Mycopathologia 1984; 85: 129–144.
Luna MA, Tortoledo ME. Histologic identification and pathologic patterns of disease due to Candida. In: Bodey GP, Fainstein V, eds. Candidiasis. New York: Raven, 1985: 13–27.
Kaplan W. Direct fluorescent antibody tests for the diagnosis of mycotic diseases. Ann Clin Lab Sci 1973; 3: 25–29.
Aspergillosis
Pennington JE. Aspergillus lung disease. Med Clin North Am 1980;64:475–490.
Greene R. The pulmonary aspergilloses: Three distinct entities or a spectrum of disease. Radiology 1981; 140: 527–530.
Katzenstein AL, Liebow AA, Friedman PJ. Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. Am Rev Respir Dis 1975; 111: 497–537.
Koss MN, Hochholzer L., Feigin DS, Garantis JC, Ward PA. Necrotizing sarcoid-like granulomatosis: Clinical, pathologic, and immunopathologic findings. Hum Pathol 1980; 11: 510–519.
Greene R. Opportunistic pneumonias. Semin Roentgenol 1980; 15: 50–72.
Myerowitz RL. The pathology of opportunistic infections with pathogenetic, diagnostic, and clinical correlations. New York: Raven, 1983: 115–128.
Rippon JW. Medical mycology: The pathogenic fungi and the pathogenic actinomycetes. 3rd Ed. Philadelphia: WB Saunders, 1988: 618–650.
Young RC, Bennett JE, Vogel CL, Carbone PP, De Vita VT. Aspergillosis: The spectrum of the disease in 98 patients. Medicine (Baltimore) 1970; 49: 147–173.
Pena CE. Aspergillosis. In: Baker RD, ed. The pathologic anatomy of mycoses: Human infection with fungi, actinomycetes and algae. Berlin: Springer-Verlag, 1971: 762–831.
Young RC, Jennings A, Bennett JE. Species identification of invasive aspergillosis in man. Am J Clin Pathol 1972; 58: 554–557.
Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: A discrete clinical entity. Medicine (Baltimore) 1982; 61: 109–124.
Weiland D, Ferguson RM, Peterson PK, Snover DC, Simmons RL, Najarian JS. Aspergillosis in 25 renal transplant patients: Epidemiology, clinical presentation, diagnosis, and management. Ann Surg 1983; 198: 62 2629.
Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis: Influence of bone marrow recovery in patients with acute leukemia. Am Rev Respir Dis 1985; 131: 115–120.
White CJ, Kwon-Chung KJ, Gatlin JI. Chronic granulo-matous disease of childhood: An unusual case of infection with Aspergillus nidulans var. echinulatus. Am J Clin Pathol 1988; 90: 312–316.
Hara KS, Ryu JH, Lie JT, Roberts GD. Disseminated Aspergillus terreus infection in immunocompromised hosts. Mayo Clin Proc 1989; 64: 770–775.
Raper KB, Fennell DI. The genus Aspergillus. Baltimore: Williams & Wilkins, 1965.
Bardana EJ. Pulmonary aspergillosis. In: Al-Doory Y, Wagner GE, eds. Aspergillosis. Springfield: Thomas, 1985: 43–78.
British Thoracic and Tuberculosis Association. Aspergilloma and residual tuberculous cavities: The results of a resurvey. Tubercle 1970; 51: 227–245.
Aslam PA, Eastridge CE, Hughes FA. Aspergillosis of the lung-an eighteen-year experience. Chest 1971; 59: 28–32.
Freundlich IM, Israel HL. Pulmonary aspergillosis. Clin Radio’ 1973; 24: 248–253.
Pennington JE. Opportunistic fungal pneumonias: Aspergillus, Mucor, Candida, Torulopsis. In: Pennington JE, ed. Respiratory infections: Diagnosis and management. New York: Raven, 1983: 329–339.
Glimp RA, Bayer AS. Pulmonary aspergilloma: Diagnostic and therapeutic considerations. Arch Intern Med 1983; 143: 303–308.
McGregor DH, Papasian CJ, Pierce PD. Aspergilloma within cavitating pulmonary adenocarcinoma. Am J Clin Pathol 1989; 91: 100–103.
Sinclair AJ, Rossof AH, Coltman CA. Recognition and successful management in pulmonary aspergillosis in leukemia. Cancer 1978; 42: 2019–2024.
Przyjemski C, Mattii R. The formation of pulmonary mycetomata. Cancer 1980; 46: 1701–1704.
Henderson AH, English MP, Vecht RJ. Pulmonary aspergillosis: A survey of its occurrence in patients with chronic lung disease and a discussion of the significance of diagnostic tests Thorax 1968; 23: 513–518.
Klein DL, Gamsu G. Thoracic manifestations of aspergillosis. AJR 1980; 134: 543–552.
Niimi T, Kajita M, Saito H. Necrotizing bronchial aspergillosis in a patient receiving neoadjuvant chemotherapy for non-small cell lung cancer. Chest 1991; 100: 277–279.
Pervez NK, Kleinerman J, Kattan M, et al. Pseudomembranous necrotizing bronchial aspergillosis: A variant of invasive aspergillosis in a patient with hemophilia and acquired immune deficiency syndrome. Am Rev Respir Dis 1985; 131: 961–963.
Kramer Mr, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis 1991; 144: 552–556.
Clarke A, Skelton J, Fraser RS. Fungal tracheobronchitis. Report of 9 cases and review of the literature. Medicine (Baltimore) 1991; 70: 1–14.
Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT.“Semi-invasive” pulmonary aspergillosis: A new look at the spectrum ofAspergillus infections of the lung. Radiology 1981;140:313–321.
Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 1991; 46: 15–20.
Diamond RD, Krzesicki R, Epstein B, Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro: A possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol 1978; 91: 313–328.
Schaffner A, Douglas H, Braude A. Selective protection against conida by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest 1982; 69: 617–631.
Meyer RD, Young LS, Armstrong D, Yu B. Aspergillosis complicating neoplastic disease. Am J Med 1973; 54: 6–15.
Orr DP, Myerowitz RL, Dubois PJ. Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer 1978; 41: 2028–2039.
Herbert PA, Bayer AS. Fungal pneumonia (part 4): Invasive pulmonary aspergillosis. Chest 1981; 80: 220225.
Fisher BD, Armstrong D, Yu B, Gold JWM. Invasive aspergillosis: progress in early diagnosis and treatment. Am J Med 1981; 71: 571–577.
Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100: 345–351.
Sidransky H, Friedman L. The effect of cortisone and antibiotic agents on experimental pulmonary aspergillosis. Am J Pathol 1959; 35: 169–183.
Davies SF, Sarosi GA. Aspergillosis in the immunosuppressed patient. In: Al-Doory Y, Wagner GE, eds. Aspergillosis. Springfield: Thomas, 1985: 96–114.
Brown E, Freedman S, Arbeit R, Come S. Invasive pulmonary aspergillosis in an apparently nonimmunocompromised host. Am J Med 1980; 69: 624 627.
Cooper JAD, Weinbaum DL, Aldrich TK, Mandell GL. Invasive aspergillosis of the lung and pericardium in a nonimmunocompromised 33-year-old man. Am J Med 1981; 71: 903–907.
Rogers TR, Haynes KA, Barnes RA. Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet 1990;ií:1210–1213.
Libshitz HI, Pagani JJ. Aspergillosis and mucormycosis: Two types of opportunistic fungal pneumonia. Radiology 1981; 140: 301–306.
Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. CT of invasive pulmonary aspergillosis. AJR 1988; 150: 1015–1020.
Rousey SR, Russler S, Gottlieb M, Ash RC. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. Am J Med 1991; 91: 484 492.
Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989; 86: 791–800.
Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991; 324: 654–662.
Nime FA, Hutchins GM. Oxalosis caused by Aspergillus infection. Johns Hopkins Med J 1973; 133: 183–194.
Kurrein F, Green GH, Rowles SL. Localized deposition of calcium oxalate around a pulmonary Aspergillus niger fungus ball. Am J Clin Pathol 1975; 64: 556–563.
Pore RS, Larsh HW. Aleuriospore formation in four related Aspergillus species. Mycologia 1967; 59: 318–325.
Phillips P, Weiner MH. Invasive aspergillosis diagnosed by immunohistochemistry with monoclonal and poly-clonal reagents. Hum Pathol 1987; 18: 1015–1024.
Schwarz J. Aspergillosis. Pathol Annu 1973; 8: 81–107.
Lemos LB, Jensen AB. Pathology of aspergillosis. In: Al-Doory Y, Wagner GE, eds. Aspergillosis. Springfield: Thomas, 1985: 156–195.
Kibbler CC, Milkins SR, Bhamra A, Spiteri MA, Noone P, Prentice HG. Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients. Thorax 1988; 43: 108–112.
Khoo TK, Sugai K, Leong TK. Disseminated aspergillosis: Case report and review of the world literature. Am J ClinPathol 1966; 45: 697–703.
Boon AP, O’Brien D, Adams DH. Ten year review of invasive aspergillosis detected at necropsy. J Clin Pathol 1991; 44: 452–454.
Mucormycosis
Baker RD. The phycomycoses. Ann NY Acad Sci 1970; 174: 592–605.
Hutter RVP. Phycomycetous infection (mucormycosis) in cancer patients: A complication of therapy. Cancer 1959; 12: 330–350.
Straatsma BR, Zimmerman LE, Gass JDM. Phycomycosis: A clinicopathologic study of fifty-one cases. Lab Invest 1962; 11: 963–985.
Baker RD. Mucormycosis (opportunistic phycomycosis). In: Baker RD, ed. The pathologic anatomy of mycoses: Human infection with fungi, actinomycetes and algae. Berlin: Springer-Verlag, 1971: 832–918.
Meyer RD, Rosen P, Armstrong D. Phycomycosis complicating leukemia and lymphoma. Ann Intern Med 1972; 77: 871–879.
Meyer RD, Armstrong D. Mucormycosis-changing status. CRC Grit Rev Clin Lab Sci 1973; 4: 421–451.
Lehrer RI, moderator. Mucormycosis. Ann Intern Med 1980; 93 (Part 1): 93–108.
Marchevsky AM, Bottone EJ, Geller SA, Giger DK. The changing spectrum of disease, etiology, and diagnosis of mucormycosis. Hum Pathol 1980; 11: 457–464.
Ingram CW, Sennesh J, Cooper JN, Perfect JR. Disseminated zygomycosis: Report of four cases and review. Rev Infect Dis 1989; 11: 741–754.
Ferry AP, Abedi S. Diagnosis and management of rhinoorbitocerebral mucormycosis (phycomycosis): A report of 16 personally observed cases. Ophthalmology 1983; 90: 1096–1104.
Neame P, Rayner D. Mucormycosis: A report on twenty-two cases. Arch Pathol 1960; 70: 261–268.
Lyon DT, Schubert TT, Mantia AG. Phycomycosis of the gastrointestinal tract. Am J Gastroenterol 1979; 72: 379–394.
Windus DW, Stokes TJ, Julian BA, Fenves AZ. Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine. Ann Intern Med 1987; 107: 678–680.
Murray HW. Pulmonary mucormycosis: One hundred years later. Chest 1977; 72: 1–2.
Baker RD. Pulmonary mucormycosis. Am J Pathol 1956; 32: 287–313.
Murray HW. Pulmonary mucormycosis with massive fatal hemoptysis. Chest 1975; 68: 65–68.
Passamonte PM, Dix JD. Nosocomial pulmonary mucormycosis with fatal massive hemoptysis. Am J Med Sci 1985; 289: 65–67.
Bartrum RJ, Watnick M, Herman PG. Roentgenographic findings in pulmonary mucormycosis. Am J Roentgenol Radium Ther Nucl Med 1973; 117: 810815.
Myerowitz RL. The pathology of opportunistic infections with pathogenetic, diagnostic, and clinical correlations. New York: Raven, 1983: 129–135.
Leong ASY. Granulomatous mediastinitis due to Rhizopus species. Am J Clin Pathol 1978; 70: 103–107.
Chandler FW, Watts JC, Kaplan W, Hendry AT, McGinnis MR, Ajello L. Zygomycosis: Report of four cases with formation of chlamydoconidia in tissue. Am J Clin Pathol 1985; 84: 99–103.
Espinoza CG, Halkias DG. Pulmonary mucormycosis as a complication of chronic salicylate poisoning. Am J Clin Pathol 1983; 80: 508–511.
Medoff G, Kobayashi GS. Pulmonary mucormycosis. N Engl J Med 1972; 286: 86–87.
Brown JF, Gottlieb LS, McCormick Pulmonary and rhinocerebral mucormycosis: Successful outcome with amphotericin B and griseofulvin therapy. Arch Intern Med 1977; 137: 936–938.
DeSouza R, MacKinnon S, Spagnolo SV, Fossieck BE. Treatment of localized pulmonary phycomycosis. South Med J 1979; 72: 609–612.
Coccidioidomycosis
Drutz DJ. Coccidioidal pneumonia. In: Pennington JE, ed. Respiratory infections: Diagnosis and management. New York: Raven, 1983: 353–373.
Drutz DJ, Catanzaro A. Coccidioidomycosis: part I. Am Rev Respir Dis 1978; 117: 559–585.
Rippon JW. Medical mycology: The pathogenic fungi and the pathogenic actinomycetes. 3rd Ed. Philadelphia: W.B. Saunders, 1988: 433–469.
Drutz DJ, Huppert M. Coccidioidomycosis: Factors affecting the host-parasite interaction. J Infect Dis 1983; 147: 372–390.
Sun SH, Cole GT, Drutz DJ, Harrison JL. Electron-microscopic observations of the Coccidioides immitis parasitic cycle in vivo. J Med Vet Mycol 1986; 24: 183–192.
Meyer PR, Hui AN, Biddle M. Coccidioides immitis meningitis with arthroconidia in cerebrospinal fluid: Report of the first case and review of the arthroconidia literature. Hum Pathol 1982; 13: 1136–1138.
Fiese MJ. Coccidioidomycosis. Springfield: Thomas, 1958.
Drutz DJ, Catanzaro A. Coccidioidomycosis: Part II. Am Rev Respir Dis 1978; 117: 727–771.
Bayer AS. Fungal pneumonias; pulmonary coccidioidal syndromes (part I): Primary and progressive primary coccidioidal pneumonias-diagnostic, therapeutic, and prognostic considerations. Chest 1981; 79: 575–583.
Bayer AS. Fungal pneumonias: pulmonary coccidioidal syndromes (part 2): Miliary, nodular, and cavitary pulmonary coccidioidomycosis; chemotherapeutic and surgical considerations. Chest 1981; 79: 686–691.
Birsner JW. The roentgen aspects of five hundred cases of pulmonary coccidioidomycosis. Am J Roentgenol Radium Ther Nucl Med 1954; 72: 556–573.
Greendyke WH, Resnick DL, Harvey WC. The varied roentgen manifestations of primary coccidioidomycosis. Am J Roentgenol Radium Ther Nucl Med 1970; 109: 491–499.
McGahan JP, Graves DS, Palmer PES, Stadalnik RC, Dublin AB. Classic and contemporary imaging of coccidioidomycosis. AJR 1981; 136: 393–404.
Deresinsky SC, Stevens DA. Coccidioidomycosis in compromised hosts. Medicine (Baltimore) 1974; 54: 377395.
Wack EE, Ampel NM, Galgiani JN, Bronnimann DA. Coccidioidomycosis during pregnancy: An analysis of ten cases among 47,120 pregnancies. Chest 1988; 94: 376–379.
MacDonald N, Steinhoff MC, Powell KR. Review of coccidioidomycosis in immunocompromised children. Am J Dis Child 1981; 135: 553–556.
Forbus WD, Bestebreurtje AM. Coccidioidomycosis: A study of 95 cases of the disseminated type with special reference to the pathogenesis of the disease. Mil Surg 1946;99:653–719.
Huntington RW. Coccidioidomycosis. In: Baker RD, ed. The pathology anatomy of mycoses: Human infection with fungi, actinomycetes, and algae. Berlin: Springer-Verlag, 1971: 147–210.
Winn WR, Finegold SM, Huntington RW. Coccidioidomycosis with fungemia. In: Ajello L. ed. Coccidioidomycosis: The second symposium on coccidioidomycosis. Tucson: Univ. Arizona Press, 1967: 93–109.
Ampel NM, Ryan KJ, Carry PJ, Wieden MA, Schifman RB. Fungemia due to Coccidioides immitis: An analysis of 16 episodes in 15 patients and a review of the literature. Medicine (Baltimore) 1986; 65: 312–321.
Galgiani JN, Ampel NM. Coccidioidomycosis in human immunodeficiency virus-infected patients. J Infect Dis
:1165–1169.
Huntington RW, Waldmann WJ, Sargent JA, O’Connell H, Wybel R, Croll D. Pathologic and clinical observations on 142 cases of fatal coccidioidomycosis with necropsy. In: Ajello L, ed. Coccidioidomycosis: The second symposium on coccidioidomycosis. Tucson: Univ. Arizona Press, 1967: 143–167.
Putnam JS, Harper WK, Greene JF, Nelson KG, Zurek RC. Coccidioides immitis: A rare cause of pulmonary mycetoma. Am Rev Respir Dis 1975; 112: 733–738.
FeeHJ, McAvoy JM, Michals AA, Gold PM. Unusual manifestation of Coccidioides immitis infection. J Thorac Cardiovasc Surg 1977; 74: 548–550.
Thadepalli H, Salem FA, Mandat AK, Rambhatla K, Einstein HE. Pulmonary mycetoma due to Coccidioides immitis. Chest 1977; 71: 429–430.
Rohatgi PK, Schmitt RG. Pulmonary coccidioidal mycetoma. Am J Med Sci 1984; 287: 27–30.
Graham AR, Sobonya RE, Bronnimann DA, Galgiani JN. Quantitative pathology of coccidioidomycosis in acquired immunodeficiency syndrome. Hum Pathol 1988; 19: 800–806.
Deppisch LM, Donowho EM. Pulmonary coccidioidomycosis. Am J Clin Pathol 1972; 58: 489–500.
Lombard CM, Tazelaar HD, Krasne DL. Pulmonary eosinophilia in coccidioidal infections. Chest 1987; 91: 734–736.
Freedman SI, Ang EP, Haley RS. Identification of coccidioidomycosis of the lung by fine needle aspiration biopsy. Acta Cytol 1986; 30: 420–424.
Howard PF, Smith JW. Diagnosis of disseminated coccidioidomycosis by liver biopsy. Arch Intern Med 1983; 143: 1335–1338.
Bayer AS, Yoshikawa TT, Galpin JE, Guze LB. Unusual syndromes of coccidioidomycosis: Diagnostic and therapeutic considerations. Medicine (Baltimore) 1976; 55: 131–152.
McClatchie S,Warambo MW, Bremner AD. Myospherulosis: A previously unreported disease? Am J Clin Pathol 1969; 51: 699–704.
Kyriakos M. Myospherulosis of the paranasal sinuses, nose and middle ear: A possible iatrogenic disease. Am J Clin Pathol 1977; 67: 118–130.
Rosai J. The nature of myospherulosis of the upper respiratory tract. Am J Clin Pathol 1978; 69: 475–481.
Travis WD, Li CY, Weiland LH. Immunostaining for hemoglobin in two cases of myospherulosis. Arch Pathol Lab Med 1986; 110: 763–765.
Pseudallescheriasis
Jung JY, Salas R, Almond CH, Saab S, Reyna R. The role of surgery in the management of pulmonary monosporiosis: A collective review. J Thorac Cardiovasc Surg 1977; 73: 139–144.
Lutwick LI, Galgiani JN, Johnson RH, Stevens DA. Visceral fungal infections due to Petriellidium boydii (Allescheria boydii): In vitro drug sensitivity studies. Am J Med 1976; 61:632–640.
Winston DJ, Jordan MC, Rhodes J. Allescheria boydii infections in the immunosuppressed host. Am J Med 1977; 63: 830–835.
Lake FR, Tribe AE, McAleer R, Froudist J, Thompson PJ. Mixed allergic bronchopulmonary fungal disease due to Pseudallescheria boydii and Aspergillus. Thorax 1990; 45: 489–492.
McGinnis MR, Padhye AA, Ajello L. Pseudallescheria Negroni et Fischer, 1943 and its later synonym Petriellidium Malloch, 1970. Mycotaxon 1982; 14: 94–102.
Arnett JC, Hatch HB. Pulmonary allescheriasis: Report of a case and review of the literature. Arch Intern Med 1975; 135: 1250–1253.
Rippon JW, Carmichael JW. Petriellidiosis (Allescheriosis): Four unusual cases and review of literature. Mycopathologia 1976;58:117–124.
Dworzack DL, Clark RB, Borkowski WJ, et al. Pseudallescheria boydii brain abscess: Association with near-drowning and efficacy of high dose, prolonged miconazole therapy in patients with multiple abscesses. Medicine (Baltimore) 1989; 68: 218–224.
Shih LY, Lee N. Disseminated petriellidiosis (allescheriasis) in a patient with refractory acute lymphoblastic leukaemia. J Clin Pathol 1984; 37: 78–82.
Reddy PC, Christianson CS, Gorelick DF, Larsh HW. Pulmonary monosporiosis: An uncommon pulmonary mycotic infection. Thorax 1969; 24: 722–728.
Hainer JW, Ostrow JH, Mackenzie DWR. Pulmonary monosporiosis: Report of a case with precipitating antibody. Chest 1974; 66: 601–603.
Bakerspigel A, Wood T, Burke S. Pulmonary allescheriasis: Report of a case from Ontario, Canada. Am J Clin Pathol 1977; 68: 299–303.
Kathuria SK, Rippon J. Non-aspergillus aspergilloma. Am J Clin Pathol 1982; 78: 870–873.
Louria DB, Lieberman PH, Collins HS, Blevins A. Pulmonary mycetoma due to Allescheria boydii. Arch Intern Med 1966; 117: 748–751.
Travis RE, Ulrich EW, Phillips S. Pulmonary allescheriasis. Ann Intern Med 1961; 54: 141–152.
McCarthy DS, Longbottom JL, Riddell RW, Batten JC. Pulmonary mycetoma due to Allescheria boydii. Am Rev Respir Dis 1969; 100: 213–216.
DeMent SH, Smith RRL, Karp JE, Merz WG. Pulmonary, cardiac, and thyroid involvement in disseminated Pseudallescheria boydii (letter). Arch Pathol Lab Med 1984; 108: 859–861.
Enggano IL, Hughes WT, Kalwinsky DK, Pearson TA, Parham DM, Stass SA. Pseudallescheria boydii in a patient with acute lymphoblastic leukemia. Arch Pathol Lab Med 1984; 198: 619–622.
Smith AG, Crain SM, Dejongh C, Thomas GM, Vigorito RD. Systemic pseudallescheriasis in a patient with acute myelocytic leukemia. Mycopathologia 1985; 90: 85–89.
Walker DH, Adamec T, Krigman M. Disseminated petriellidiosis (allescheriosis). Arch Pathol Lab Med 1978; 102: 158–160.
Saadah HA, Dixon T. Petriellidium boydii (Allescheria boy dii): necrotizing pneumonia in a normal host. JAMA 1981; 245: 605–606.
Alture-Werber E, Edberg SC, Singer JM. Pulmonary infection with Allescheria boydii. Am J Clin Pathol 1976; 66: 1019–1024.
Schwartz DA. Organ-specific variation in the morphology of the fungomas (fungus balls) of Pseudallescheria boydii. Arch Pathol Lab Med 1989; 113: 476–480.
Travis LB, Roberts GD, Wilson WR. Clinical significance of Pseudallescheria boydii: A review of 10 years’ experience. Mayo Clin Proc 1985; 60: 531–537.
Fusariosis
Young NA, Kwon-Chung KJ, Kubota TT, Jennings AE, Fisher RI. Disseminated infection by Fusarium monili-forme during treatment for malignant lymphoma. J Clin Microbiol 1978; 7: 589–594.
Wheeler MS, McGinnis MR, Schell WA, Walker DH. Fusarium infection in burned patients. Am J Clin Pathol 1981; 75: 304–311.
Blazar BR, Hurd DD, Snover DC, Alexander JW, McGlave PB. Invasive Fusarium infections in bone marrow transplant recipients. Am J Med 1984; 77: 645–651.
Summerbell RC, Richardson SE, Kane J. Fusarium prolif eratum as an agent of disseminated infection in an immunosuppressed patient. J Clin Microbiol 1988; 26: 82–87.
Abramowsky CR, Quinn D, Bradford WD, Conant NF. Systemic infection by Fusarium in a burned child: The emergence of a saprophytic strain. J Pediatr 1974; 84: 561–564.
Cho CT, Vats Ts, Lowman JT, Brandsberg JW, Tosh FE. Fusarium solani infection during treatment for acute leukemia. J Pediatr 1973; 83: 1028–1031.
Venditti M, Micozzi A, Gentile G, et al. Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis 1988; 10: 653–660.
Anaissie E, Kantarjian H, Ro J, et al. The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) 1988; 67: 77–83.
Richardson SE, Bannatyne RM, Summerbell RC, Milliken J, Gold R, Weitzman SS. Disseminated fusarial infection in the immunocompromised host. Rev Infect Dis 1988; 10: 1171–1181.
Mutton KJ, Lucas TJ, Harkness JL. Disseminated Fusarium infection. Med J Aust 1980; 2: 624–625.
Young CN, Meyers AM. Opportunistic fungal infection by Fusarium oxysporum in a renal transplant patient. Sabouraudia 1979; 17: 219–223.
Gutmann L, Chou SM, Pore RS. Fusariosis, myasthenic syndrome, and aplastic anemia. Neurology 1975; 25: 922–926.
Trichosporonosis
Rivera R, Cangir A. Trichosporon sepsis and leukemia. Cancer 1975; 36: 1106–1110.
Evans HL, Kletzel M, Lawson RD, Frankel LS, Hopfer RL. Systemic mycosis due to Trichosporon cutaneum: A report of two additional cases. Cancer 1980; 45: 367–371.
Yung CW, Hanauer SB, Fretzin D, Rippon JW, Shapiro C, Gonzalez M. Disseminated Trichosporon beigelii (cutaneum). Cancer 1981; 48: 2107–2111.
Saul SH, Khachatoorian T, Poorsattar A, et al. Opportunistic Trichosporon pneumonia: association with invasive aspergillosis. Arch Pathol Lab Med 1981; 105: 456459.
Gardella S, Nomdedeu B, Bombi JA, et al. Fatal fungemia with arthritic involvement caused by Trichosporon beigelii in a bone marrow transplant recipient (letter). J Infect Dis 1985; 151: 566.
Madhaven T, Eisses J. Systemic infections due to Trichosporon cutaneum, an uncommon pathogen (abstr). Am J Clin Pathol 1975; 63: 598.
Winston DJ, Balsley GE, Rhodes J, Linne SR. Disseminated Trichosporon capitatum infection in an immunosuppressed host. Arch Intern Med 1977; 137: 1192–1195.
Martino P, Venditti M, Micozzi A, et al. Blastoschizomyces capitatus: An emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis 1990; 12: 570–582.
Kirmani N, Tuazon CU, Geelhoed GW. Disseminated Trichosporon infection: occurrence in an immunosuppressed patient with chronic active hepatitis. Arch Intern Med 1980; 140: 277–278.
Jameson B, Carter RL, Watson JG, Hay RJ. An unexpected fungal infection in a patient with leukaemia. J Clin Pathol 1981; 34: 267–270.
Gold JWM, Poston W, Mertelsmann R, et al. Systemic infection with Trichosporon cutaneum in a patient with acute leukemia. Cancer (Phila) 1981; 48: 2163–2167.
Manzella JP, Berman IJ, Kukrika MD. Trichosporon beigelii fungemia and cutaneous dissemination. Arch Dermatol 1982; 118: 343–345.
Brahn E, Leonard Pa. Trichosporon cutaneum endocarditis: A sequela of intravenous drug abuse. Am J Clin Pathol 1982; 78: 792–794.
Libertin CR, Davies NJ, Halper J, Edson RS, Roberts GD. Invasive disease caused by Trichosporon beigelii. Mayo Clin Proc 1983; 58: 684–686.
Haupt HM, Merz WG, Beschorner WE, Vaughan WP, Saral R. Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis 1983; 147: 199–203.
Bhansali S, Karanes C, Palutke W, Crane L, Kiel R, Ratanatharathorn V. Successful treatment of disseminated Trichosporon beigelii (cutaneum) infection with associated splenic involvement. Cancer (Phila) 1986; 58: 1630–1632.
Leblond V, Saint-Jean O, Datry A, et al. Systemic infections with Trichosporon beigelii (cutaneum). Cancer (Phila) 1986; 58: 2399–2405.
Walling DM, McGraw DJ, Merz WG, Karp JE, Hutchins GM. Disseminated infection with Trichosporon beigelii. Rev Infect Dis 1987; 9: 1013–1019.
Ito T, Ishikawa Y, Fujii R, et al. Disseminated Trichosporon capitatum. Cancer (Phila) 1988; 61: 585–588.
Ness MJ, Markin RS, Wood RP, Shaw BW, Woods GL. Disseminated Trichosporon beigelii infection after orthotopic liver transplantation. Am J Clin Pathol 1989; 92: 119–123.
Kimura M, Takahashi H, Satou T, Hashimoto S. An autopsy case of disseminated trichosporonosis with candidiasis of the urinary bladder. Virchows Arch A [Pathol Anal] 1989; 416: 159–162.
Ogata K, Tanabe Y, Iwakiri K, et al. Two cases of disseminated Trichosporon beigelii infection treated with combination antifungal therapy. Cancer (Phila) 1990; 65: 2793–2795.
Kobayashi M, Kotani S, Fujishita M, et al. Immunohistochemical identification of Trichosporon beigelii in histologic section by immunoperoxidase method. Am J Clin Pathol 1988; 89: 100–105.
Takeuchi T, Kobayashi M, Moriki T, Miyoshi I. Application of a monoclonal antibody for the detection of Trichosporon beigelii in paraffin-embedded tissue sections. J Pathol 1988; 156: 23–27.
Geotrichosis
Morenz J. Geotrichosis. In: Baker RD, ed. The pathologic anatomy of mycoses: Human infection with fungi, actinomycetes and algae. Berlin: Springer-Verlag, 1971: 919–952.
Sheehy TW, Honeycutt BK, Spency JT. Geotrichum septicemia. JAMA 1976; 235: 1035–1037.
Webster BH. Bronchopulmonary geotrichosis. Dis Chest 1959; 35: 273–281.
Ross JD, Reid KDG, Speirs CF. Bronchopulmonary geotrichosis with severe asthma. Br Med J 1962; 1: 1400 1402.
Ghamande AR, Landis FB, Snider GL. Bronchial geotrichosis with fungemia complicating bronchial carcinoma. Chest 1971; 59: 98–101.
Fishbach RS, White ML, Finegold SM. Bronchopulmonary geotrichosis. Am Rev Respir Dis 1973; 108: 1388 1392.
Chang WWL, Buerger L. Disseminated geotrichosis. Arch Intern Med 1964; 113: 356–360.
Jagirdar J, Geller SA, Bottone EJ. Geotrichum candidum as a tissue invasive human pathogen. Hum Pathol 1981; 12: 668–671.
Winer-Muram HT. Geotrichosis: Who is susceptible? (letter). Chest 1988; 94: 1315–1316.
Hamilton-Miller JMT. A comparative in vitro study of amphotericin B, clotrimazole and 5-fluorocytosine against clinically isolated yeasts. Sabouraudia 1972; 10: 276–283.
Penicilliosis Marneffei
Pitt JI. The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces. New York: Academic Press, 1979.
Tsang DNC, Chan JKC, Lau YT, et al. Penicillium marneffei infection: An underdiagnosed disease? Histopathology 1988;13:311–318.
Deng Z, Connor DH. Progressive disseminated penicilliosis caused by Penicillium marneffei. Report of eight cases and differentiation of the causative organism from Histoplasma capsulatum. Am J Clin Pathol 1985; 84: 323327.
Tsang DNC, Li PCK, Tsui MS, et al. Penicillium marneffei: Another pathogen to consider in patients infected with human immunodeficiency virus. Rev Infect Dis 1991; 13: 766–767.
Deng Z, Ribas JL, Gibson DW, Connor DH. Infections caused by Penicillium marneffei in China and Southeast Asia. Review of eighteen published-cases and report of four more Chinese cases. Rev Infect Dis 1988; 10: 640652.
Segretain G. Description d’une nouvelle espece de penicillium: Penicillium marneffei, n. sp. Bull Soc Mycol Fr 1959; 75: 412–416.
DiSalvo AF, Fickling AM, Ajello L. Infection caused by Penicillium marneffei: Description of first natural infection in man. Am J Clin Pathol 1973; 60: 259–263.
Pautler KB, Padhye AA, Ajello L. Imported penicilliosis marneffei in the United States: Report of a second human infection. Sabouraudia 1984; 22: 433–438.
Jayanetra P, Nitiyanant P, Ajello L, et al. Penicilliosis marneffei in Thailand: Report of five human cases. Am J Trop Med Hyg 1984; 33: 637–644.
So SY, Chau PY, Jones BM, et al. A case of invasive penicilliosis in Hong Kong with immunologic evaluation. Am Rev Respir Dis 1984; 131: 662–665.
Chan JKC, Tsang DNC, Wong DKK. Penicillium marneffei in bronchoalveolar lavage fluid. Acta Cytol 1989; 33: 533–536.
Malasseziasis
Marcon MJ, Powell DA. Human infections due to Malassezia spp. Clin Microbiol Rev 1992; 5: 101–119.
Bertini B, Kuttin ES, Beemer AM. Cytopathology of nipple discharge due to Pityrosporum orbiculare and cocci in an elderly woman. Acta Cytol 1975; 19: 38–42.
Oberle AD, Fowler M, Grafton WD. Pityrosporum isolate from the upper respiratory tract. Am J Clin Pathol 1981; 76: 112–116.
Wallace M, Bagnall H, Glen D. Isolation of lipophilic yeast in “sterile” peritonitis. Lancet 1979;íi:956.
Redline RW, Redline SS, Boxerbaum B, Dahms BB. Systemic Malasseziafurfur infections in patients receiving intralipid therapy. Hum Pathol 1985; 16: 815–822.
Dankner WM, Spector SA, Fierer J, Davis CE. Malasse-zia fungemia in neonates and adults: Complication of hyperalimentation. Rey Infect Dis 1987; 9: 743–753.
Marcon MJ, Powell DA. Epidemiology, diagnosis and management of Malassezia furfur systemic infection. Diagn Microbiol Infect Dis 1987; 7: 161–175.
Shek YH, Tucker MC, Viciana AL, Manz HJ, Connor DH. Malassezia furfur-Disseminated infection in premature infants. Am J Clin Pathol 1989; 92: 595–603.
Weiss SJ, Schoch PE, Cunha BA. Malassezia furfur fungemia associated with central venous catheter lipid emulsion infusion. Heart Lung 1991; 20: 87–90.
Phaeohyphomycosis
Ajello L. Phaeohyphomycosis: definition and etiology. In: Mycoses. Sci Pub 304. Washington DC: Pan American Health Organization, 1975: 126–133.
McGinnis MR. Human pathogenic species of Exophiala, Phialophora and Wangiella. In: The black and white yeasts. Sci Pub 356. Washington, DC: Pan American Health Organization, 1978: 37–59.
McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: New concepts, diagnosis, and mycology. J Am Acad Dermatol 1983; 8: 1–16.
Fader RC, McGinnis MR. Infections caused by dematiaceous fungi: Chromoblastomycosis and phaeohyphomycosis. Infect Dis Clin North Am 1988; 2: 925–938.
Ichinose H. Subcutaneous abscesses due to brown fungi. In: Baker RD, ed. The pathologic anatomy of mycoses: Human infection with fungi, actinomycetes and algae. Berlin: Springer-Verlag, 1971: 719–730.
Ziefer A, Connor DH.Phaeomycotic cyst. A clinico-pathologic study of twenty-five patients. Am J Trop Med ‘Hyg 1980; 29: 901–911.
Bambirra EA, Miranda D,Nogueira AMF, Barbosa CSP. Phaeohyphomycotic cyst: A clinicopathologic study of the first four cases described from Brazil. Am J Trop Med Hyg 1983; 32: 794–798.
Moskowitz LB, Cleary TJ, McGinnis Mr, Thomson CB. Phialophora richardsiae in a lesion appearing as a giant cell tumor in the tendon sheath. Arch Pathol Lab Med 1983; 107: 374–376.
Tschen JA, Knox JM, McGavran MH, Duncan WC. Chromomycosis, the association of fungal elements and wood splinters. Arch Dermatol 1984; 120: 107–108.
Riley O Jr, Mann SH. Brain abscess caused by Cladosporium trichoides: Review of 3 cases and report of fourth case. Am J Clin Pathol 1960; 33: 525–531.
Crichlow DK, Enrile FT,Memon MY. Cerebellar abscess due to Cladosporium trichoides (bantianum): case report. Am J Clin Pathol 1973; 60: 416 421.
Chandramukki A, Ramadevi MG, Shankar SK. Cerebral cladosporiosis-a neuropathological and microbiological study. Clin Neurol Neurosurg 1983; 85: 245–253.
Seaworth BJ, Kwon-Chung KJ, Hamilton JD, Perfect JR. Brain abscess caused by a variety of Cladosporium trichoides. Am J Clin Pathol 1983; 79: 747–752.
Dixon DM, Walsh TJ, Merz WG, McGinnis MR. Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis 1989; 11: 515–525.
McGinnis MR, Borelli D, Padhye AA, Ajello L. Reclassification of Cladosporium bantianum in the genus Xylohypha. J Clin Microbiol 1986; 23: 1148–1151.
Dixon DM, Merz WG, Elliot HL, Macleay S. Experimental central nervous system phaeohyphomycosis following intranasal inoculation of Xylohypha bantiana in cortisone-treated mice. Mycopathologia 1987; 100: 145–153.
Fink JN, Schlueter DP, Barboriak JJ. Hypersensitivity pneumonitis due to exposure to Alternaria. Chest 1973; 63: 49S.
McAleer R,Kroenert DB, Elder JL, FroudistJH. Allergic bronchopulmonary disease caused by Curvularia lunata and Drechslera hawaiiensis. Thorax 1981; 36: 338–344.
Limsila T, Stituimankaru T, Thasnakorn P. Pulmonary cladosporoma. Report of a case. J Med Assoc Thailand 1970; 53: 586–590.
Lampert RP, Hutto JH, Donnelly WH, Shulman ST. Pulmonary and cerebral mycetoma caused by Curvularia pallescens. J Pediatr 1977; 91: 603–605.
de la Monte SM, Hutchins GM. Disseminated Curvularia infection. Arch Pathol Lab Med 1985; 109: 872–874.
Lobritz RW, Roberts TH, Marraro RV, Carlton PK, Thorp DJ. Granulomatous pulmonary disease secondary to Alternaria. JAMA 1979; 241: 596–597.
Borges MC, Jr., Warren S, White W, Pellettiere EV. Pulmonary phaeohyphomycosis due to Xylohypha bantiana. Arch Pathol Lab Med 1991; 115: 627–629.
Rohwedder JJ, Simmons JL, Colfer H, Gatmaitan B. Disseminated Curvularia lunata infection in a football player. Arch Intern Med 1979; 139: 940–941.
Ferraro FA, Morgan MA. A case of disseminated Phialophora parasitica infection. Arch Pathol Lab Med 1989; 113: 1379–1381.
Hay RJ, Dupont B, Graybill JR, eds. First international symposium on itraconazole. Rev Infect Dis 1987;9 (Suppl.):Sl-152.
Adiaspiromycosis
Kodousek R. Adiaspiromycosis. Acta Univ Palacki Olomuc Fac Med 1974; 70: 5–68.
Schwarz J. Adiaspiromycosis. Pathol Annu 1978; 13: 41–53.
Emmons CW, Binford CH, Utz JP, Kwon-Chung KJ. Medical mycology. 3d Ed. Philadelphia: Lea & Febiger, 1977: 493–505.
Barbas Filho JV, Amato MBP, Deheinzelin D, Saldiva RHN, de Carvalho CRR. Respiratory failure caused by adiaspiromycosis. Chest 1990; 97: 1171–1175.
Cueva JA, Little MD. Emmonsia crescens infection (adiaspiromycosis) in man in Honduras. Am J Trop Med Hyg 1971; 20: 282–287.
Kodousek R, Vortel V, Fingerland A, et al. Pulmonary adiaspiromycosis in man caused by Emmonsia crescens: Report of a unique case. Am J Clin Pathol 1971; 56: 394399.
Watts JC, Callaway CS, Chandler FW, Kaplan W. Human pulmonary adiaspiromycosis. Arch Pathol 1975; 99: 11–15.
Rhinosporidiosis
Karunaratne WAE. Rhinosporidiosis in man. London: Athlone, 1964.
Rippon JW. Medical mycology: The pathogenic fungi and the pathogenic actinomycetes. 3rd Ed. Philadelphia: W.B. Saunders, 1988:718–721.
Levy MG, Meuten DJ, Breitschwerdt EB. Cultivation of Rhinosporidium seeberi in vitro: Interaction with epithelial cells. Science 1986; 234: 474–476.
Rajam RV, Viswanathan GS, Rao AR, Rangiah PN, Anguli VS. Rhinosporidiosis: A study with report of a fatal case of systemic dissemination. Indian J Surg 1955; 17: 269–298.
Agrawal S, Sharma KD, Shrivastava JB. Generalized rhinosporidiosis with visceral involvement: Report of a case. Arch Dermatol 1959; 80: 22–26.
Bader G, Grueber HLE. Histochemical studies of Rhinosporidium seeberi. Virchows Arch [Pathol Anat] 1970; 350: 76–86.
Kannan-Kutty M, Teh EC. Rhinosporidium seeberi: An electron microscopy study of its life cycle. Pathology 1974; 6: 63–70.
Kannan-Kutty M, Teh EC. Rhinosporidium seeberi: An ultrastructural study of its endosporulation phase and trophocyte phase. Arch Pathol 1975; 99: 51–54.
Savino DF, Margo CE. Conjunctival rhinosporidiosis: Light and electron microscopic study. Ophthalmology 1983; 90: 1482–1489.
Protothecosis
Kaplan W. Protothecosis and infections caused by morphologically similar green algae. In: The black and white yeasts. Sci Pub 356. Washington DC: Pan American Health Association, 1978: 218–232.
Sudman MS. Protothecosis: A critical review. Am J Clin Pathol 1974; 61: 10–19.
Sudman MS, Kaplan W. Identification of the Prototheca species by immunofluorescence. Appl Microbiol 1973; 25: 981–990.
Conner DH, Gibson DW, Ziefer A. Diagnostic features of three unusual infections: micronemiasis, pheomycotic cyst, and protothecosis. In: Majno G, Cotran RS, Kaufman N, eds. Current topics in inflammation and infection. International Academy of Pathology monograph no. 23. Baltimore: Williams & Wilkins, 1982:205–239.
Naryshkin S, Frank I, Nachamkin I. Prototheca zopfii isolated from a patient with olecranon bursitis. Diagn Microbiol Infect Dis 1987; 6: 171–174.
Davies RR, Wilkinson JL. Human protothecosis: supplementary studies. Ann Trop Med Parasitol 1967; 61: 11 2115.
Cox GE, Wilson JD, Brown P. Protothecosis: a case of disseminated algal infection. Lancet 1974;ii:379–382.
Venezio FR, Lavoo E, Williams JW, et al. Progressive cutaneous protothecosis. Am J Clin Pathol 1982; 77: 485–493.
Chan JC, Jeffers LJ, Gould EW, et al. Visceral protothecosis mimicking sclerosing cholangitis in an immunocompetent host: Successful antifungal therapy. Rev Infect Dis 1990; 12: 802–807.
Nosanchuk JS, Greenberg RD. Protothecosis of the olecranon bursa caused by achloric algae. Am J Clin Pathol 1973; 59: 567–573.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chandler, F.W., Watts, J.C. (1994). Fungal Infections. In: Dail, D.H., Hammar, S.P. (eds) Pulmonary Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3935-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3935-0_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-3937-4
Online ISBN: 978-1-4757-3935-0
eBook Packages: Springer Book Archive